KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CRISPR Therapeutics AG (CRSP) Minority Interest (2016)

CRISPR Therapeutics AG (CRSP) has disclosed Minority Interest for 2 consecutive years, with -$51000.0 as the latest value for Q3 2016.

  • Quarterly Minority Interest changed N/A to -$51000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was -$51000.0 through Sep 2016, changed N/A year-over-year, with the annual reading at -$27000.0 for FY2015, N/A changed from the prior year.
  • Minority Interest hit -$51000.0 in Q3 2016 for CRISPR Therapeutics AG, down from -$27000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$27000.0 in Q4 2015 to a low of -$51000.0 in Q3 2016.